Yomeishu sees major shareholder shift, ends Taisho alliance

Yomeishu Seizo (TSE:2540) announced that Taisho Pharmaceutical Holdings, its major shareholder, has agreed to transfer all its Yomeishu shares to Yuzawa Co. Ltd. The transaction, structured as a secondary offering, involves 3,300,000 shares priced at ¥2,394 each, totaling ¥7,900,200,000. Following the transfer, Yuzawa will become Yomeishu's primary shareholder, holding 23.69% of outstanding shares. As a result of the share transfer, Yomeishu and Taisho Pharmaceutical will terminate their existing capital and business alliance, effective March 21, 2025. Yomeishu anticipates no significant impact on its financial performance from these changes.